Arterial Stents Market

Table of Content

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Market Size (US$ Mn) and Forecast, by Region, 2022 and 2032

    3.2. Global Market: Market Snapshot

4. Market Overview

    4.1. Global Market Overview

    4.2. Global Market Key Industry Developments

5. Market Dynamics

    5.1. Drivers and Restraints Snapshot Analysis

    5.2. Drivers

    5.3. Restraints

    5.4. Opportunities

    5.5. Key Trends

    5.6. Global Market Revenue Projections (US$ Mn), 2022–2032

    5.7. Market: Mergers & Acquisitions

    5.8. Ker Arterial Diseases: Epidemiology

        5.8.1. Coronary Artery Diseases (CAD)

        5.8.2. Peripheral Artery Diseases (PAD)

    5.9. Challenges Faced by Biosimilar Product to be Approved in U.S. Market

    5.10. Regulatory Framework

    5.11. Heat Map Analysis - Company

6. Global Market Analysis, by Product Type

    6.1. Introduction

    6.2. Key Insights

    6.3. Global Market Size and Forecast, by Product Type

        6.3.1. Coronary Stents

            6.3.1.1. Bare Metal Stents

            6.3.1.2. Drug-eluting Stents

            6.3.1.3. Bioresorbable Stents

            6.3.1.4. Others

        6.3.2. Peripheral Stents

            6.3.2.1. Self-expanding Stents

            6.3.2.2. Balloon-expanding Stents

            6.3.2.3. Others

    6.4. Global Market Analysis, by Product Type

    6.5. Global Market Attractiveness Analysis, by Product Type

7. Global Market Analysis, by Application

    7.1. Introduction

    7.2. Key Insights

    7.3. Global Market Size and Forecast, by Application

        7.3.1. Coronary Artery

        7.3.2. Carotid Artery

        7.3.3. Iliac Artery

        7.3.4. Femoral & Popliteal Artery

        7.3.5. Others

    7.4. Global Market Analysis, by Application

    7.5. Global Market Attractiveness Analysis, by Application

8. Global Market Analysis, by Region

    8.1. Introduction

    8.2. Key Insights

    8.3. Global Market Size and Forecast, by Region, 2014–2025

        8.3.1. North America

        8.3.2. Europe

        8.3.3. Asia Pacific

        8.3.4. Latin America

        8.3.5. Middle East & Africa

    8.4. Global Market Analysis, by Region

    8.5. Global Market Attractiveness Analysis, by Region

9. North America Market Analysis

    9.1. North America Market Key Findings

    9.2. North America Market Overview

    9.3. North America Market Size and Forecast, by Product Type

        9.3.1. Coronary Stents

            9.3.1.1. Bare Metal Stents

            9.3.1.2. Drug-eluting Stents

            9.3.1.3. Bioresorbable Stents

            9.3.1.4. Others

        9.3.2. Peripheral Stents

            9.3.2.1. Self-expanding Stents

            9.3.2.2. Balloon-expanding Stents

            9.3.2.3. Others

        9.3.3. North America Market Analysis, by Product Type

    9.4. North America Market Size and Forecast, by Application

        9.4.1. Coronary Artery

        9.4.2. Carotid Artery

        9.4.3. Iliac Artery

        9.4.4. Femoral & Popliteal Artery

        9.4.5. Others

    9.5. North America Market Forecast, by Country

        9.5.1. U.S.

        9.5.2. Canada

    9.6. North America Market Attractiveness Analysis

        9.6.1. By Product Type

        9.6.2. By Application

        9.6.3. By Country

10. Europe Market Analysis

    10.1. Europe Market Key Findings

    10.2. Europe Market Overview

    10.3. Europe Market Size and Forecast, by Product Type

        10.3.1. Coronary Stents

            10.3.1.1. Bare Metal Stents

            10.3.1.2. Drug-eluting Stents

            10.3.1.3. Bioresorbable Stents

            10.3.1.4. Others

        10.3.2. Peripheral Stents

            10.3.2.1. Self-expanding Stents

            10.3.2.2. Balloon-expanding Stents

            10.3.2.3. Others

    10.4. Europe Market Size and Forecast, by Application

        10.4.1. Coronary Artery

        10.4.2. Carotid Artery

        10.4.3. Iliac Artery

        10.4.4. Femoral & Popliteal Artery

        10.4.5. Others

    10.5. Europe Market Forecast, by Country

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Rest of Europe

    10.6. Europe Market Attractiveness Analysis

        10.6.1. By Product Type

        10.6.2. By Application

        10.6.3. By Country

11. Asia Pacific Market Analysis

    11.1. Asia Pacific Market Key Findings

    11.2. Asia Pacific Market Overview

    11.3. Asia Pacific Cytometry Market Size and Forecast, by Product Type

        11.3.1. Coronary Stents

            11.3.1.1. Bare Metal Stents

            11.3.1.2. Drug-eluting Stents

            11.3.1.3. Bioresorbable Stents

            11.3.1.4. Others

        11.3.2. Peripheral Stents

            11.3.2.1. Self-expanding Stents

            11.3.2.2. Balloon-expanding Stents

            11.3.2.3. Others

    11.4. Asia Pacific Market Size and Forecast, by Application

        11.4.1. Coronary Artery

        11.4.2. Carotid Artery

        11.4.3. Iliac Artery

        11.4.4. Femoral & Popliteal Artery

        11.4.5. Others

    11.5. Asia Pacific Market Forecast, by Country

        11.5.1. China

        11.5.2. India

        11.5.3. Japan

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Asia Pacific Market Attractiveness Analysis

        11.6.1. By Product Type

        11.6.2. By Application

        11.6.3. By Country

12. Latin America Market Analysis

    12.1. Latin America Market Key Findings

    12.2. Latin America Market Overview

    12.3. Latin America Cytometry Market Size and Forecast, by Product Type

        12.3.1. Coronary Stents

            12.3.1.1. Bare Metal Stents

            12.3.1.2. Drug-eluting Stents

            12.3.1.3. Bioresorbable Stents

            12.3.1.4. Others

        12.3.2. Peripheral Stents

            12.3.2.1. Self-expanding Stents

            12.3.2.2. Balloon-expanding Stents

            12.3.2.3. Others

    12.4. Latin America Market Size and Forecast, by Application

        12.4.1. Coronary Artery

        12.4.2. Carotid Artery

        12.4.3. Iliac Artery

        12.4.4. Femoral & Popliteal Artery

        12.4.5. Others

    12.5. Latin America Market Forecast, by Country

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Latin America Market Attractiveness Analysis

        12.6.1. By Product Type

        12.6.2. By Application

        12.6.3. By Country

13. Middle East & Africa Market Analysis

    13.1. Middle East & Africa Market Key Findings

    13.2. Middle East & Africa Market Overview

    13.3. Middle East & Africa Cytometry Market Size and Forecast, by Product Type

        13.3.1. Coronary Stents

            13.3.1.1. Bare Metal Stents

            13.3.1.2. Drug-eluting Stents

            13.3.1.3. Bioresorbable Stents

            13.3.1.4. Others

        13.3.2. Peripheral Stents

            13.3.2.1. Self-expanding Stents

            13.3.2.2. Balloon-expanding Stents

            13.3.2.3. Others

    13.4. Middle East & Africa Market Size and Forecast, by Application

        13.4.1. Coronary Artery

        13.4.2. Carotid Artery

        13.4.3. Iliac Artery

        13.4.4. Femoral & Popliteal Artery

        13.4.5. Others

    13.5. Middle East & Africa Market Size and Forecast, by Country

        13.5.1. GCC Countries

        13.5.2. Israel

        13.5.3. South Africa

        13.5.4. Rest of Middle East & Africa

    13.6. Middle East Market Attractiveness Analysis

        13.6.1. By Product Type

        13.6.2. By Application

        13.6.3. By Country

14. Competition Landscape

    14.1. Global Market Share Analysis, by Company (2022)

    14.2. Company Profiles

        14.2.1. Abbott Vascular (Abbott Laboratories)

            14.2.1.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.1.2. Financials

            14.2.1.3. Recent Developments

            14.2.1.4. Strategy

        14.2.2. Cordis Corporation (A Cardinal Health Company)

            14.2.2.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.2.2. Financials

            14.2.2.3. Recent Developments

            14.2.2.4. Strategy

        14.2.3. Boston Scientific Corporation

            14.2.3.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.3.2. Financials

            14.2.3.3. Recent Developments

            14.2.3.4. Strategy

        14.2.4. Medtronic

            14.2.4.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.4.2. Financials

            14.2.4.3. Recent Developments

            14.2.4.4. Strategy

        14.2.5. C. R. Bard, Inc. (BARD Peripheral Vascular)

            14.2.5.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.5.2. Financials

            14.2.5.3. Recent Developments

            14.2.5.4. Strategy

        14.2.6. Biosensors International Group, Ltd.

            14.2.6.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.6.2. Financials

            14.2.6.3. Recent Developments

            14.2.6.4. Strategy

        14.2.7. Lifetech Scientific

            14.2.7.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.7.2. Financials

            14.2.7.3. Recent Developments

            14.2.7.4. Strategy

        14.2.8. BIOTRONIK AG

            14.2.8.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.8.2. Financials

            14.2.8.3. Recent Developments

            14.2.8.4. Strategy

        14.2.9. Cook Medical

            14.2.9.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.9.2. Financials

            14.2.9.3. Recent Developments

            14.2.9.4. Strategy

        14.2.10. W. L. Gore & Associates, Inc.

            14.2.10.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.10.2. Financials

            14.2.10.3. Recent Developments

            14.2.10.4. Strategy

List Of Table

Table 01: Global Market Size (US$ Mn) Analysis, by Product Type, 2017–2021

Table 02: Global Market Size (US$ Mn) Forecast, by Product Type, 2022–2032

Table 03: Global Market Size (US$ Mn) Analysis, by Coronary Stents, 2017–2021

Table 04: Global Market Size (US$ Mn) Forecast, by Coronary Stents, 2022–2032

Table 05: Global Market Size (US$ Mn) Analysis, by Peripheral Stents, 2017–2021

Table 06: Global Market Size (US$ Mn) Forecast, by Peripheral Stents, 2022–2032

Table 07: Global Market Size (US$ Mn) Analysis, by Application, 2017–2021

Table 08: Global Market Size (US$ Mn) Forecast, by Application, 2022–2032

Table 09: Global Market Size (US$ Mn) Analysis, by Coronary Artery , 2017–2021

Table 10: Global Market Size (US$ Mn) Forecast, by Coronary Artery , 2022–2032

Table 11: Global Market Size (US$ Mn) Analysis, by Carotid Artery , 2017–2021

Table 12: Global Market Size (US$ Mn) Forecast, by Carotid Artery, 2022–2032

Table 13: Global Market Size (US$ Mn) Analysis, by Iliac Artery, 2017–2021

Table 14: Global Market Size (US$ Mn) Forecast, by Iliac Artery, 2022–2032

Table 15: Global Market Size (US$ Mn) Analysis, by Femoral & Popliteal Artery, 2017–2021

Table 16: Global Market Size (US$ Mn) Forecast, by Femoral & Popliteal Artery, 2022–2032

Table 17: Global Market Size (US$ Mn) Analysis, by Others, 2017–2021

Table 18: Global Market Size (US$ Mn) Forecast, by Others, 2022–2032

Table 19: Global Market Size (US$ Mn) Analysis, by Region, 2017–2021

Table 20: Global Market Size (US$ Mn) Forecast, by Region, 2022–2032

Table 21: North America Market Size (US$ Mn) Analysis, by Product Type, 2017–2021

Table 22: North America Market Size (US$ Mn) Forecast, by Product Type, 2022–2032

Table 23: North America Market Size (US$ Mn) Analysis, by Application, 2017–2021

Table 24: North America Market Size (US$ Mn) Forecast, by Application, 2022–2032

Table 25: North America Market Size (US$ Mn) Analysis, by Country, 2017–2021

Table 26: North America Market Size (US$ Mn) Forecast, by Country, 2022–2032

Table 27: Europe Market Size (US$ Mn) Analysis, by Product Type, 2017–2021

Table 28: Europe Market Size (US$ Mn) Forecast, by Product Type, 2022–2032

Table 29: Europe Market Size (US$ Mn) Analysis, by Application, 2017–2021

Table 30: Europe Market Size (US$ Mn) Forecast, by Application, 2022–2032

Table 31: Europe Market Size (US$ Mn) Analysis, by Country, 2017–2021

Table 32: Europe Market Size (US$ Mn) Forecast, by Country, 2022–2032

Table 33: Asia Pacific Market Size (US$ Mn) Analysis, by Product Type, 2017–2021

Table 34: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2022–2032

Table 35: Asia Pacific Market Size (US$ Mn) Analysis, by Application, 2017–2021

Table 36: Asia Pacific Market Size (US$ Mn) Forecast, by Application, 2022–2032

Table 37: Asia Pacific Market Size (US$ Mn) Analysis, by Country, 2017–2021

Table 38: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2022–2032

Table 39: Latin America Market Size (US$ Mn) Analysis, by Product Type, 2017–2021

Table 40: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2022–2032

Table 41: Latin America Market Size (US$ Mn) Analysis, by Application, 2017–2021

Table 42: Latin America Market Size (US$ Mn) Forecast, by Application, 2022–2032

Table 43: Latin America Market Size (US$ Mn) Analysis, by Country, 2017–2021

Table 44: Latin America Market Size (US$ Mn) Forecast, by Country, 2022–2032

Table 45: MEA Market Size (US$ Mn) Analysis, by Product Type, 2017–2021

Table 46: MEA Market Size (US$ Mn) Forecast, by Product Type, 2022–2032

Table 47: MEA Market Size (US$ Mn) Analysis, by Application, 2017–2021

Table 48: MEA Market Size (US$ Mn) Forecast, by Application, 2022–2032

Table 49: MEA Market Size (US$ Mn) Analysis, by Country, 2017–2021

Table 50: MEA Market Size (US$ Mn) Forecast, by Country, 2022–2032

Table 51: U.S. Market Size (US$ Mn), 2022-2032

Table 52: Canada Market Size (US$ Mn), 2022-2032

Table 53: Brazil Market Size (US$ Mn), 2022-2032

Table 54: Mexico Market Size (US$ Mn), 2022-2032

Table 55: Argentina Market Size (US$ Mn), 2022-2032

Table 56: Germany Market Size (US$ Mn), 2022-2032

Table 57: France Market Size (US$ Mn), 2022-2032

Table 58: Italy Market Size (US$ Mn), 2022-2032

Table 59: Spain Market Size (US$ Mn), 2022-2032

Table 60: U.K. Market Size (US$ Mn), 2022-2032

Table 61: Benelux Market Size (US$ Mn), 2022-2032

Table 62: Russia Market Size (US$ Mn), 2022-2032

Table 63: China Market Size (US$ Mn), 2022-2032

Table 64: Japan Market Size (US$ Mn), 2022-2032

Table 65: South Korea Market Size (US$ Mn), 2022-2032

Table 66: India Market Size (US$ Mn), 2022-2032

Table 67: Thailand Market Size (US$ Mn), 2022-2032

Table 68: Indonesia Market Size (US$ Mn), 2022-2032

Table 69: Malaysia Market Size (US$ Mn), 2022-2032

Table 70: Australia & New Zealand Market Size (US$ Mn), 2022-2032

Table 71: GCC Countries Market Size (US$ Mn), 2022-2032

Table 72: Egypt Market Size (US$ Mn), 2022-2032

Table 73: South Africa Market Size (US$ Mn), 2022-2032

Table 74: Turkey Market Size (US$ Mn), 2022-2032

List Of Figures

Figure 01: Global Market Size (US$ Mn) Forecast, 2022–2032

Figure 02: Global Market Value Share, by Product (2022)

Figure 03: Global Market Value Share, by Application (2022)

Figure 04: Global Market Value Share, by Region (2022)

Figure 05: Global Prevalence of CAD, By Country, 2022

Figure 06: Global Prevalence of CAD (%), By Age Group and Gender, 2022

Figure 07: Global Prevalence of PAD (%), By Age Group and Gender, 2017

Figure 08: Global Coronary Stents Volume Forecast (‘000), 2022–2032

Figure 09: Global Peripheral Stents Volume Forecast (‘000), 2022–2032

Figure 10: Global Market Value Share, by Product, 2022 and 2032

Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Coronary Stents, 2022–2032

Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Peripheral Stents, 2022–2032

Figure 13: Global Market Attractiveness, by Product, 2022–2032

Figure 14: Global Market Value Share, by Application, 2022 and 2032

Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Iliac Artery, 2022–2032

Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Carotid Artery, 2022–2032

Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Coronary Artery, 2022–2032

Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Femoral & Popliteal Artery, 2022–2032

Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2022–2032

Figure 20: Global Market Attractiveness, by Application, 2022–2032

Figure 21: Global Market Value Share, by Region, 2022 and 2032

Figure 22: Global Market Attractiveness, by Region, 2022–2032

Figure 23: North America Market Value Share, by Country, 2022 and 2032

Figure 24: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 25: North America Market Attractiveness, by Country, 2022–2032

Figure 26: North America Market Value Share, by Product, 2022 and 2032

Figure 27: North America Market Attractiveness, by Product, 2022–2032

Figure 28: North America Market Value Share, by Application, 2022 and 2032

Figure 29: North America Market Attractiveness, by Application, 2022–2032

Figure 30: Europe Market Value Share, by Country/Sub-region, 2022 and 2032

Figure 31: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 32: Europe Market Attractiveness, by Country/Sub-region, 2022–2032

Figure 33: Europe Market Value Share, by Product, 2022 and 2032

Figure 34: Europe Market Attractiveness, by Product, 2022–2032

Figure 35: Europe Market Value Share, by Application, 2022 and 2032

Figure 36: Europe Market Attractiveness, by Application, 2022–2032

Figure 37: Asia Pacific Market Value Share, by Country/Sub-region, 2022 and 2032

Figure 38: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 39: Asia Pacific Market Attractiveness, by Country/Sub-region, 2022–2032

Figure 40: Asia Pacific Market Value Share, by Product, 2022 and 2032

Figure 41: Asia Pacific Market Attractiveness, by Product, 2022–2032

Figure 42: Asia Pacific Market Value Share, by Application, 2022 and 2032

Figure 43: Asia Pacific Market Attractiveness, by Application, 2022–2032

Figure 44: Latin America Market Value Share, by Country, 2022 and 2032

Figure 45: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 46: Latin America Market Attractiveness, by Country, 2022–2032

Figure 47: Latin America Market Value Share, by Product, 2022 and 2032

Figure 48: Latin America Market Attractiveness, by Product, 2022–2032

Figure 49: Latin America Market Value Share, by Application, 2022 and 2032

Figure 50: Latin America Market Attractiveness, by Application, 2022–2032

Figure 51: Middle East & Africa Market Value Share, by Country, 2022 and 2032

Figure 52: Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022–2032

Figure 53: Middle East & Africa Market Attractiveness, by Country, 2022–2032

Figure 54: Middle East & Africa Market Value Share, by Product, 2022 and 2032

Figure 55: Middle East & Africa Market Attractiveness, by Product, 2022–2032

Figure 56: Middle East & Africa Market Value Share, by Application, 2022 and 2032

Figure 57: Middle East & Africa Market Attractiveness, by Application, 2022–2032

Figure 58: Global Market Share, by Company, 2022

Figure 59: Abbott Laboratories Revenue (US$ Bn) and Y-o-Y Growth (%), 2017-2021

Figure 60: Abbott Laboratories Breakdown of Net Sales (%), by Region, 2022

Figure 61: Cardinal Health Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2021

Figure 62: Cardinal Health Breakdown of Net Sales (%), by Business Segment, 2022

Figure 63: Medtronic Revenue (US$ Bn) & Y-o-Y Growth (%), 2017-2021

Figure 64: Medtronic Breakdown of Net Sales (%), by Region, 2022

Figure 65: Boston Scientific Corporation Revenue (US$ Bn) and Y-o-Y Growth (%), 2017-2021

Figure 66: Boston Scientific Corporation Breakdown of Net Sales (%), by Region, 2022

Figure 67: Lifetech Scientific Revenue (US$ Mn) & Y-o-Y Growth (%), 2017-2021

Figure 68: C. R. Bard, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2022

Figure 69: C. R. Bard, Inc. Breakdown of Net Sales (%), by Business Segment, 2022